Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure
- 1 October 2001
- journal article
- case report
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 28 (8), 783-785
- https://doi.org/10.1038/sj.bmt.1703234
Abstract
A 30-year-old Japanese woman weighing 35 kg with severe hemochromatosis due to multiple transfusions was referred to our clinic for treatment of severe aplastic anemia (SAA). The patient had heart failure with an ejection fraction of 36% requiring diuretics and a severe liver dysfunction with an indocyanine green clearance rate of 18%, as well as other transfusion-related complications such as chronic hepatitis due to hepatitis C virus and diabetes mellitus. She was treated with a non-myeloablative preparative regimen that included fludarabine monophosphate (Flu, 120 mg/m2), cyclophosphamide (CY, 1200 mg/m2) and antithymocyte globulin (ATG, 15 mg/kg) followed by allogeneic peripheral blood stem cell transplantation (PBSCT) from her HLA-matched sister. The regimen was well tolerated, and engraftment rapidly occurred without any therapy-related complications. Chimerism analysis on day 14 after transplant showed reconstitution with 100% donor cells. She no longer needed transfusion after day 23 and has been well in 90% Karnofsky status at 4 months post transplant. The clinical course of this patient indicates that this preparative regimen enables SAA patients with severe organ failure to safely undergo allogeneic stem cell transplantation. Bone Marrow Transplantation (2001) 28, 783–785.Keywords
This publication has 11 references indexed in Scilit:
- Umbilical cord blood transplantation from unrelated HLA-matched donor in an adult with severe aplastic anemiaBone Marrow Transplantation, 2000
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000
- American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy ProtectantsJournal of Clinical Oncology, 1999
- Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients.Journal of Clinical Oncology, 1998
- Decreased Rejection and Improved Survival of First and Second Marrow Transplants for Severe Aplastic Anemia (A 26-Year Retrospective Analysis)Blood, 1998
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Journal of Clinical Oncology, 1998
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- A fludarabine-based protocol for bone marrow transplantation in Fanconi’s anemiaBone Marrow Transplantation, 1997
- Validation of highly discriminating multiplex short tandem repeat amplification systems for individual identificationElectrophoresis, 1996
- BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA—A STUDY OF TWENTY-ONE CHINESE PATIENTS IN TAIWANTransplantation, 1992